CBMJ
Get informed when a big investor buys or sells
+ FollowOvervalued by 241.3% based on the discounted cash flow analysis.
| Market cap | $21,838.00 |
|---|---|
| Enterprise Value | $452,798.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.03 |
| Beta | 1.34 |
| Outstanding Shares | 61,625,452 |
| P/E Ratio | -0.31 |
|---|---|
| PEG | -0.01 |
| Price to Sales | - |
| Price to Book Ratio | -0.01 |
| Enterprise Value to Revenue | 3.48 |
| Enterprise Value to EBIT | -0.73 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.98 |
| Debt to Equity | 2.49 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data